Investors looking to join fundamental growth momentum with timely technical entry points often face the challenge of sorting through large amounts of data. A specific method involves looking for stocks that show solid recent earnings momentum, positive analyst revisions, and speeding growth, qualities measured by ChartMill's High Growth Momentum (HGM) Rating, while also showing firm price trends and constructive consolidation patterns, as measured by the Technical and Setup Quality Ratings. This method tries to find companies where strong fundamental drivers are matching with favorable chart structures, possibly indicating a preparation for a new move upward.
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) appears from such a search, presenting a case for review by growth-focused investors. The company, a global pharmaceutical firm centered on treatments for substance-use disorders and opioid overdose, has shown a notable fundamental improvement.
Fundamental Growth Momentum
INDV's attraction for a high-growth momentum method is based on its sharp earnings recovery and positive estimate revisions. The HGM Rating of 6 shows strength across several important criteria needed for this investing style:
- Outstanding EPS Growth: The company's trailing twelve-month EPS has jumped by over 256% year-over-year. While recent quarterly growth has been uneven, the most recent quarter showed a firm 33% year-over-year increase, and analysts forecast growth of about 115% for the next quarter.
- Steady Earnings Surprises: A key idea of momentum investing is companies outperforming expectations. INDV has topped EPS estimates in each of the last four quarters, with an average surprise of 70.5%.
- Positive Analyst Revisions: Forward-looking confidence is shown by notable upward revisions to estimates. The average EPS estimate for the next year has been revised upward by almost 80% over the last three months, pointing to solid and increasing belief in the company's profit path.
- Growing Profitability: The last reported quarterly profit margin of 13.4% shows a significant increase from the 6.0% margin in the previous quarter, hinting at better operational efficiency along with top-line growth.
While revenue growth has been more moderate lately, the strong mix of large earnings expansion, steady beats, and climbing analyst forecasts creates the fundamental "momentum" that high-growth methods try to capture.
Technical Strength and Setup Quality
A solid fundamental story is most effective when joined by a supportive price chart. According to ChartMill's technical report, INDV gets an 8 for both its Technical Rating and its Setup Quality Rating.
Technical Health (Rating: 8): The high technical score highlights INDV's position as a market leader. Important points from the report include:
- Long-Term Uptrend: The long-term trend is labeled positive, with the stock trading well above its key rising moving averages (100-day and 200-day).
- Excellent Relative Strength: INDV has done better than 98% of all stocks in the market over the past year and is in the top 7% of its Pharmaceuticals industry group. This superior relative performance is a sign of leading growth stocks.
- Consolidation Within a Range: Lately, the stock has been trading between about $32.81 and $36.03, absorbing its earlier large gains in a healthy way.
Setup Quality (Rating: 8): The equally high setup score shows this consolidation may be forming a possible base. The analysis notes that prices have been tightening, with a clear resistance zone found just above the current price around $36.22 to $36.61. A clear breakout above this zone could signal the restart of the primary uptrend. The report also finds defined support levels near $34.34, which can help investors handle risk by giving a logical area for a stop-loss order.
Conclusion
For investors using a high-growth momentum method, INDV presents an interesting profile. The company is in the middle of a strong earnings recovery cycle, regularly beating expectations, and seeing notable upward revisions from analysts, all core parts of the growth momentum idea. Technically, the stock stays in a solid long-term uptrend with excellent relative strength and is currently holding in a consolidation pattern that presents a clear possible entry point. The match of these fundamental and technical factors suggests INDV is a stock deserving of further review for those looking for growth chances with defined risk parameters.
This analysis was based on a particular search for stocks with a High Growth Momentum Rating above 4, a Technical Rating above 7, and a Setup Rating above 7. Investors curious about finding other companies that currently meet these conditions can review the live results via this High Growth Momentum Breakout Setups Screen.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. The analysis is based on data provided and search conditions that may change. Investors should perform their own due diligence and consider their individual financial situation and risk tolerance before making any investment decisions.
